Doctor profile · Federal record

Dr. Michael Sonabend, MD

Specialist (CMS: Dermatology) · Sugar Land, TX

  • NPI 1578696936
  • Accepts Medicare
  • MIPS 99.2 / 100 · 2023
  • 23 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
7616 Branford Pl Ste 240
Sugar Land, TX 774793794
(281) 240-4313
fax (281) 240-3646

Credentials & registration

NPPES · NUCC
NPI registered
March 2007 — 19 yrs on file
Profile last updated
January 18, 2021
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
174400000X — NUCC code
State license (1)
Texas #M5515

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1578696936. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,115
Distinct HCPCS
10
Medicare allowed
$228,815
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,063 269 $6
17000 Destruction of precancer skin growth, 1 growth 708 432 $46
88305 Pathology examination of tissue using a microscope, intermediate complexity 662 369 $33
99213 Established patient office or other outpatient visit, 20-29 minutes 604 391 $87
11102 Biopsy of related skin growth, first growth 362 260 $90
99214 Established patient office or other outpatient visit, 30-39 minutes 247 179 $121
17110 Destruction of skin growth, 1-14 growths 150 130 $104
11103 Biopsy of related skin growth, each additional growth 65 44 $49
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 46 46 $289
99203 New patient office or other outpatient visit, 30-44 minutes 35 35 $109

In context: peer comparison

Among 10 peers in Sugar Land Specialist, average services per provider: 2,303. This provider delivers 1.8× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$27,998
Transactions
220
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 55 $23,811.09
Janssen Biotech, INC. 24 $654.72
Regeneron Healthcare Solutions, INC. 14 $376.17
Genzyme Corporation 7 $354.45
Lilly USA, LLC 16 $353.09
Novartis Pharmaceuticals Corporation 12 $344.53
Ucb, INC. 9 $340.16
E.R. Squibb & Sons, L.L.C. 11 $326.35
Incyte Corporation 15 $309.04
Arcutis Biotherapeutics, INC. 13 $255.45
Amgen INC. 18 $251.07
Sun Pharmaceutical Industries INC. 8 $206.40
Dermavant Sciences, INC. 10 $156.26
Biofrontera INC. 4 $79.94
Pfizer INC. 4 $65.67

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$21,677
Food and Beverage
$5,485
Travel and Lodging
$746
Education
$90

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
442
Patients
317
Total drug cost
$66,627
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 102 77 $743
Clobetasol Propionate Generic 44 35 $1,994
Ketoconazole Generic 42 27 $735
Fluticasone Propionate Generic 35 30 $665
Fluorouracil Generic 32 32 $3,252
Fluocinonide Generic 31 25 $1,254
Hydrocortisone Generic 26 23 $136
Doxycycline Monohydrate Generic 24 15 $830
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 20 14 $497
Mupirocin Generic 18 15 $148

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Sonabend's medical specialty?
Dr. Michael Sonabend practices Specialist in Sugar Land, TX.
Where does Dr. Michael Sonabend practice?
Dr. Michael Sonabend practices at 7616 Branford Pl Ste 240, Sugar Land, TX 774793794. Office phone: 2812404313.
What is Dr. Michael Sonabend's NPI?
Dr. Michael Sonabend's National Provider Identifier (NPI) is 1578696936, issued by NPPES.
Does Dr. Michael Sonabend accept Medicare assignment?
Yes. Dr. Michael Sonabend accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Sonabend commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Pathology examination of tissue using a microscope, intermediate complexity (HCPCS 88305). Source: CMS Medicare Physician & Other Practitioners file.